Pure Biologics Spólka Akcyjna
PUR.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -PLN 19,435 | -PLN 35,694 | -PLN 25,603 | -PLN 11,765 |
| Dep. & Amort. | PLN 309 | PLN 5,784 | PLN 2,497 | PLN 2,920 |
| Deferred Tax | PLN 0 | PLN 0 | PLN 0 | PLN 34 |
| Stock-Based Comp. | PLN 0 | PLN 1,302 | PLN 4,413 | PLN 2,787 |
| Change in WC | PLN 7,266 | -PLN 4,499 | PLN 333 | -PLN 18,238 |
| Other Non-Cash | PLN 1,031 | PLN 9,845 | PLN 973 | PLN 227 |
| Operating Cash Flow | -PLN 10,829 | -PLN 23,262 | -PLN 17,387 | -PLN 24,035 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | PLN 0 | -PLN 176 | -PLN 5,758 | -PLN 673 |
| Net Acquisitions | PLN 0 | PLN 0 | PLN 25,935 | -PLN 15 |
| Inv. Purchases | PLN 0 | -PLN 3,995 | -PLN 4,885 | -PLN 36,041 |
| Inv. Sales/Matur. | PLN 0 | PLN 4,919 | PLN 25,940 | PLN 8,245 |
| Other Inv. Act. | PLN 3,559 | -PLN 357 | -PLN 25,887 | PLN 6 |
| Investing Cash Flow | PLN 3,559 | PLN 391 | PLN 15,345 | -PLN 28,478 |
| Financing Activities | – | – | – | – |
| Debt Repay. | PLN 4,421 | PLN 12,000 | -PLN 1,547 | -PLN 2,148 |
| Stock Issued | PLN 0 | PLN 18,861 | PLN 0 | PLN 52,110 |
| Stock Repurch. | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Dividends Paid | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Other Fin. Act. | -PLN 443 | -PLN 6,643 | -PLN 329 | -PLN 227 |
| Financing Cash Flow | PLN 3,978 | PLN 24,218 | -PLN 1,876 | PLN 49,735 |
| Forex Effect | PLN 0 | PLN 0 | -PLN 1 | PLN 0 |
| Net Chg. in Cash | -PLN 3,293 | PLN 1,347 | -PLN 3,919 | -PLN 2,778 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | PLN 3,606 | PLN 2,259 | PLN 6,178 | PLN 8,956 |
| End Cash | PLN 313 | PLN 3,606 | PLN 2,259 | PLN 6,178 |
| Free Cash Flow | -PLN 10,829 | -PLN 23,438 | -PLN 23,145 | -PLN 24,708 |